Arylquin 1 (Potent Par-4 Secretagogue) Inhibits Tumor Progression and Induces Apoptosis in Colon Cancer Cells

Colorectal cancer (CRC) is one of the most common gastrointestinal cancers worldwide. Current therapeutic strategies mainly involve surgery and chemoradiotherapy; however, novel antitumor compounds are needed to avoid drug resistance in CRC, as well as the severe side effects of current treatments....

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yi-Ting, Tseng, Tzu-Ting, Tsai, Hung-Pei, Huang, Ming-Yii
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143413/
https://www.ncbi.nlm.nih.gov/pubmed/35628455
http://dx.doi.org/10.3390/ijms23105645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143413/
https://www.ncbi.nlm.nih.gov/pubmed/35628455
http://dx.doi.org/10.3390/ijms23105645

Ejemplares similares